CAS 357336-19-7

BRIVARACETAM IMPURITY A CRS

CAS: 357336-19-7

BRIVARACETAM IMPURITY A CRS

Ref: 41-Y0002408

Brivaracetam Related Compound A ((S)-2-[(S)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)

CAS: 357336-19-7

Lactams, nesoi

Formel: C₁₁H₂₀N₂O₂

Farbe und Form: White Powder

Molekulargewicht: 212.15248

Ref: 45-1078041

Brivaracetam EP Impurity A (Brivaracetam USP Related Compound A)

CAS: 357336-19-7

Formel: C₁₁H₂₀N₂O₂

Farbe und Form: White To Off-White Solid

Molekulargewicht: 212.29

Ref: 4Z-B-105003

Brivaracetam (alfaS, 4S)-Isomer

CAS: 357336-19-7

Formel: C₁₁H₂₀N₂O₂

Molekulargewicht: 212.29

Ref: ST-EA-CP-B35004

(4S)-Brivaracetam

Kontrolliertes Produkt

CAS: 357336-19-7

Formel: C₁₁H₂₀N₂O₂

Farbe und Form: Neat

Molekulargewicht: 212.289

Ref: TR-B677650

(4S)-Brivaracetam-d7

Kontrolliertes Produkt

CAS: 357336-19-7

Applications (4S)-Brivaracetam-d7, is the labeled analogue of (4S)-Brivaracetam (B677650), which is an isomer of Brivaracetam (B677645), a 4-n-propyl analog of levetiracetam (L331500), and a racetam derivative with anticonvulsant properties.
References Rosenstiel, P., et al.:Neurotherapeutics, 4 (1), 84 (2007); Malawska, B., et al.:, Curr. Opin. Investig. Drugs, 6(7), 740 (2005);

Formel: C₁₁D₇H₁₃N₂O₂

Farbe und Form: Neat

Molekulargewicht: 219.332

Ref: TR-B677652

(4S)-Brivaracetam

Kontrolliertes Produkt

CAS: 357336-19-7

(4S)-Brivaracetam is a drug product that is custom synthesized by our company. It is an analytical standard for pharmacopoeia and research and development purposes. The purity of (4S)-Brivaracetam is above 99%. This drug product contains no impurities or metabolites.

Formel: C₁₁H₂₀N₂O₂

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 212.29 g/mol

Ref: 3D-IB181064